–
© Nathan Lainé
–
Pharmacist Pfizer is working hard to adapt its vaccine so that it is also resistant to the omikron variant. But that takes a lot of work. In the meantime, the new variant continues to be frantically around the world. Will we get the improved vaccine through before omikron becomes dominant everywhere? Marc Van Ranst and Geert Molenberghs assess the situation.
–
